Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) EPS (Basic): 2009-2024

Historic EPS (Basic) for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to -$6.69.

  • Assembly Biosciences' EPS (Basic) rose 52.32% to -$0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.79, marking a year-over-year increase of 30.78%. This contributed to the annual value of -$6.69 for FY2024, which is 50.00% up from last year.
  • According to the latest figures from FY2024, Assembly Biosciences' EPS (Basic) is -$6.69, which was up 50.00% from -$13.38 recorded in FY2023.
  • Assembly Biosciences' EPS (Basic)'s 5-year high stood at -$1.75 during FY2020, with a 5-year trough of -$23.08 in FY2022.
  • For the 3-year period, Assembly Biosciences' EPS (Basic) averaged around -$14.38, with its median value being -$13.38 (2023).
  • As far as peak fluctuations go, Assembly Biosciences' EPS (Basic) spiked by 52.96% in 2020, and later slumped by 669.33% in 2022.
  • Assembly Biosciences' EPS (Basic) (Yearly) stood at -$1.75 in 2020, then plummeted by 71.43% to -$3 in 2021, then crashed by 669.33% to -$23.08 in 2022, then soared by 42.03% to -$13.38 in 2023, then spiked by 50.00% to -$6.69 in 2024.